AFP and hepatocellular carcinoma: Current professional recommendations for HCC surveillance, including the Thailand HCC guideline, suggest screening using ultrasound (US) coupled with serum alpha-fetoprotein (AFP) every 6 months in patients with cirrhosis [2,7].